跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,350 条关于
“glycogen synthase kinase”
全部
4,350
临床试验
2,000
药物
529
机构
20
资讯
1,801
6年前
Overcoming Osimertinib Resistance in EGFR-Mutant NSCLC Through GSK-3 Inhibition
去年
Elraglusib Shows Promise for Advanced Salivary Gland Carcinoma in Upcoming AACR Presentation
去年
Advancements in Pompe Disease Treatment: A Pipeline Review
去年
AMO Pharma Launches Largest-Ever Clinical Trial for Rare Heart Condition ARVC with GSK3β Inhibitor AMO-02
去年
Actuate Therapeutics and Lantern Pharma Collaborate on AI-Driven Elraglusib Development
去年
Actuate Therapeutics Raises $17.25 Million to Advance GSK-3β Inhibitor for Difficult-to-Treat Cancers
2年前
Elraglusib Receives FDA Orphan Drug Designation for Soft Tissue Sarcoma
去年
Elraglusib Receives FDA Rare Pediatric Disease Designation for Ewing Sarcoma
3个月前
Integrated Machine Learning and Molecular Dynamics Framework Identifies Novel GSK-3β Inhibitor Candidates for Alzheimer's Disease
去年
Elraglusib Granted FDA Rare Pediatric Disease Designation for Ewing Sarcoma
第 1 页,共 181 页
上一页
下一页